SELDI-TOF MS serum protein profiles in breast cancer: Assessment of robustness and validity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SELDI-TOF MS serum protein profiles in breast cancer: Assessment of robustness and validity

Published:2006-12-28 Issue:6 Volume:2 Page:235-248
ISSN:1875-8592
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Gast M.C.W.¹,Bonfrer J.M.G.²,van Dulken E.J.³,de Kock L.³,Rutgers E.J.Th.⁴,Schellens J.H.M.⁵,Beijnen J.H.¹⁶

Affiliation:

1. Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands

2. Department of Clinical Chemistry, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands

3. Department of Surgery, Slotervaart Hospital, Amsterdam, The Netherlands

4. Department of Surgery, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands

5. Department of Medical Oncology, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands

6. Faculty of Pharmaceutical Sciences, Department of Biomedical Analysis, Utrecht University, Utrecht, The Netherlands

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Matrix-assisted laser desorption/ionisation (MALDI) TOF analysis identifies serum angiotensin II concentrations as a strong predictor of all-cause and breast cancer (BCa)-specific mortality following breast surgery;International Journal of Cancer;2015-06-04

2. Proteomic Profiling of Invasive Ductal Carcinoma (IDC) using Magnetic Beads-based Serum Fractionation and MALDI-TOF MS;Journal of Clinical Laboratory Analysis;2014-08-17

3. Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study;BMC Cancer;2011-08-26

4. Identification of Serum Biomarkers for Biliary Tract Cancers by a Proteomic Approach Based on Time-of-Flight Mass Spectrometry;Cancers;2010-08-18

5. Serum Degradome Markers for the Detection of Breast Cancer;Journal of Proteome Research;2010-07-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3